Medicare Enrolled

Dr. Daniel Tarquinio, D.O.

Pediatrics · Gainesville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1315 JESSE JEWELL PKWY NE STE 300, Gainesville, GA 30501
7702196520
In practice since 2006 (19 years)
NPI: 1427131168 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tarquinio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tarquinio? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tarquinio

Dr. Daniel Tarquinio is a pediatrics specialist in Gainesville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tarquinio performed 551 Medicare services across 413 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tarquinio received a total of $43,152 from 30 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tarquinio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 44% volume in GA $43,152 industry payments

Medicare Practice Summary

Medicare Utilization ↗
551
Medicare services
Top 44% in GA for pediatrics
413
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
324 $122 $291
New patient office visit, complex (60-74 min) 75 $158 $414
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
66 $24 $56
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
54 $8 $19
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $54 $220
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
12 $41 $450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$43,152
Total received (2018-2024)
Avg $6,165/year across 7 years
Top 1% in GA for pediatrics
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,174 (65.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,086 (30.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,892 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,235
2023
$9,245
2022
$8,905
2021
$4,718
2020
$6,333
2019
$3,453
2018
$262

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurelis, Inc.
$6,339
ABBVIE INC.
$2,986
PFIZER INC.
$198
SK Life Science, Inc.
$153
ACADIA Pharmaceuticals Inc
$84
UCB, Inc.
$75
Teva Pharmaceuticals USA, Inc.
$55
Otsuka America Pharmaceutical, Inc.
$54
JAZZ PHARMACEUTICALS INC.
$52
ARGENX US, INC.
$31
Eisai Inc.
$30
Vanda Pharmaceuticals Inc.
$26
CATALYST PHARMACEUTICALS, INC.
$26
Biogen, Inc.
$22
Boston Scientific Corporation
$20
Novartis Pharmaceuticals Corporation
$19
Lilly USA, LLC
$18
Alexion Pharmaceuticals, Inc.
$17
Bioventus LLC
$15
Kyowa Kirin, Inc.
$14
Top 3 companies account for 93.0% of 2024 payments
All-time payments by company (2018-2024) ›
Neurelis, Inc.
$28,174
AbbVie Inc.
$4,420
ABBVIE INC.
$2,986
ACADIA Pharmaceuticals Inc
$2,784
CIPLA USA INC.
$2,567
Marinus Pharmaceuticals, Inc.
$513
PFIZER INC.
$268
BioMarin Pharmaceutical Inc.
$237
SK Life Science, Inc.
$201
Teva Pharmaceuticals USA, Inc.
$147
UCB, Inc.
$123
ARGENX US, INC.
$116
PTC Therapeutics, Inc.
$66
Novartis Pharmaceuticals Corporation
$57
Lilly USA, LLC
$56
Otsuka America Pharmaceutical, Inc.
$54
JAZZ PHARMACEUTICALS INC.
$52
Kyowa Kirin, Inc.
$44
Eisai Inc.
$43
Lundbeck LLC
$29
Corium, LLC
$27
Vanda Pharmaceuticals Inc.
$26
CATALYST PHARMACEUTICALS, INC.
$26
Sunovion Pharmaceuticals Inc.
$25
Biogen, Inc.
$22
Boston Scientific Corporation
$20
Amgen Inc.
$19
Alexion Pharmaceuticals, Inc.
$17
Amneal Pharmaceuticals LLC
$16
Bioventus LLC
$15
Top 3 companies account for 82.5% of all-time payments
Associated products mentioned in payments ›
AMYVID · APTIOM · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · Briviact · DAYBUE · EMFLAZA · EMGALITY · EPIDIOLEX · FYCOMPA · Fintepla · KESIMPTA · L300 GO SYSTEM · LYVISPAH · Leqembi · NUPLAZID · NURTEC ODT · Nourianz · PONVORY · QALSODY · QULIPTA · REXULTI · SOLIRIS · UBRELVY · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · Vimizim · WATCHMAN FLX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatrics and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pediatrics in GA.

Looking for a pediatrics specialist in Gainesville?
Compare pediatricians in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse pediatricians nearby

Geographic Context

Pediatricians within 10 mi
118
Per 100K population
56.6
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Tarquinio is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Tarquinio experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Tarquinio performed 324 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tarquinio receive payments from pharmaceutical companies?
Yes. Dr. Tarquinio received a total of $43,152 from 30 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tarquinio's costs compare to other pediatricians in Gainesville?
Dr. Tarquinio's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tarquinio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →